Transitions

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

Polypharmacy, certain medication classes seem to worsen COVID-19 outcomes

Friday, January 14, 2022 0 27414

Pharmacists are well aware that polypharmacy is a major issue among patients, especially older adults. Recent studies have estimated that approximately 36% of older adults take at least 5 prescription medications, and 67% take 5 or more medications or supplements, including OTCs.

ISMP issues warning about possible safety issues with newly authorized...

Tuesday, January 11, 2022 0 27008

To encourage the appropriate use of Pfizer’s COVID-19 antiviral drug nirmatrelvir/ritonavir (Paxlovid), the Institute for Safe Medication Practices (ISMP) released an alert for dispensing pharmacists.

CDC releases guidance on caring for ‘COVID long-haulers’

Thousands of patients have reported experiencing a wide range of physical and mental health consequences that persist after a COVID-19...

What might this flu season have in store?

Influenza cases and deaths in the United States and worldwide dropped to unprecedented lows between October 3, 2020, and July 24, 2021, according...

Flu vaccine can protect against severe effects of COVID-19, study finds

A new study published in PLoS One suggests that the influenza vaccine may help safeguard individuals against COVID-19.

NIH researchers identify potential new antiviral drug for COVID-19

An experimental drug, 4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol), may be a promising oral antiviral treatment for COVID-19,...

Influenza vaccination during pregnancy not associated with adverse...

A new study published in JAMA Network found that maternal influenza vaccination during pregnancy was not significantly...

CDC: mRNA vaccines reduce risk of infection by 91% for fully vaccinated

For fully vaccinated individuals, the Pfizer and Moderna mRNA COVID-19 vaccines authorized by FDA lower the risk of infection by 91%,...

Monday, May 24, 2021

Naloxone prescriptions took a dive during the pandemic

New research published in JAMA Network shows that nationwide naloxone prescriptions declined at the start of the pandemic and have yet to reach pre-pandemic levels.

Thursday, May 20, 2021

FDA: Don’t use antibody testing to evaluate immunity after COVID-19 vaccination

FDA reminded health care professionals and the public that results from currently authorized COVID-19 antibody tests should not be used to assess a person’s level of immunity or protection from COVID-19 at any time, particularly after the person has received a COVID-19 vaccination.

1 2

Transitions Magazine

Polypharmacy, certain medication classes seem to worsen COVID-19 outcomes

ISMP issues warning about possible safety issues with newly authorized...

CDC releases guidance on caring for ‘COVID long-haulers’

What might this flu season have in store?

Flu vaccine can protect against severe effects of COVID-19, study finds

NIH researchers identify potential new antiviral drug for COVID-19

Influenza vaccination during pregnancy not associated with adverse...

CDC: mRNA vaccines reduce risk of infection by 91% for fully vaccinated

Naloxone prescriptions took a dive during the pandemic

FDA: Don’t use antibody testing to evaluate immunity after COVID-19 vaccination